Medical Condition

solid tumors

Total Trials

12

Recruiting Now

12

Trial Phases

Phase 2, Phase 1, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for solid tumors sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
Phase 1–4 studies from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — solid tumors Clinical Trials

How many clinical trials are currently recruiting for solid tumors?

ClinicalMetric currently tracks 12 actively recruiting clinical trials for solid tumors, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for solid tumors?

solid tumors research spans Phase 1 (11 trials), Phase 2 (6 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a solid tumors clinical trial?

Eligibility criteria for solid tumors trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Enrollment

280 pts

Location

United States, Austr...

Sponsor

Incyte Corporation

View Trial →

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology

solid tumors

Frequently Asked Questions — solid tumors Clinical Trials

Recruiting Clinical Trials

A Phase 2 Clinical Study of ABSK061 and ABSK043

QTX3034 in Patients With KRAS G12D Mutation

First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors

Study of INCB123667 in Subjects With Advanced Solid Tumors

Multicenter Phase I Study of HRS-6208 in Patients With Solid Tumors

Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors

A Study of SHR-4375 in Subjects With Solid Tumors

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

Personalized Neoantigen Peptide Vaccines for Solid Tumors

A Study of ZL-1310 in Participants With Selected Solid Tumors

DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid Tumors

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies